Vectura shares plunge on asthma drug failure
Shares in Vectura Group have fallen after the pharma company announced that development of asthma drug VR475 will be halted.
Shares in Vectura Group have fallen after the pharma company announced that development of asthma drug VR475 will be halted.
As the Withdrawal Agreement approaches its moment of truth, the UK is already plotting a course for new trading arrangements in the wider world. That’s if we are ever let out of our cage, writes Victor Hill.
With many investors expecting an upcoming major financial crash, Ranjeet Singh offers a key investment strategy that could save you tens of thousands of pounds.
Richard Gill, CFA, looks at three small-cap stocks primed for growth.
Master Investor are pleased to announce award-winning research house, QuotedData, as a key sponsor for Master Investor Show 2019. Edward Marten, QuotedData’s CEO, shall join the Main Stage line-up on Saturday, 6 April, at London’s Business Design Centre. Commenting on QuotedData’s sponsorship for a second year running, Edward Marten said: “We are really excited about…
With some expecting Brexit to have a negative impact on the stock markets, Ranjeet Singh offers two key strategies to reposition your portfolio.
The managers of the Capital Gearing Trust have issued a stark warning about the risks facing investors.
Health, safety, and environmental technology group Halma has announced the acquisition of Navtech Radar for an initial £21million consideration.
AIM-listed telematics provider Trakm8 has posted a pre-tax loss of £2.9 million for the six months ended 30th September.
When is a deal a betrayal and why is UK business frantically preparing for no-deal? Victor Hill thinks investors should focus on three key things.